目前，针对抑制性受体或配体、PD-1/PD-L1及CTLA-4的靶向免疫治疗已经取得了显著的临床成果。然而，仍有许多患者未从免疫治疗中获益。......

Objective Gastric cancer is the second leading cause of cancer-related deaths and the fifth most common malignancy world......

背景近些年来,随着现代医疗技术的研究与发展,过继性免疫治疗(adoptive immun-otherapy,AIT)显示出越来越显著的治疗效果,嵌合抗原......